Prostate Cancer Clinical Trial

Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation Program

Summary

The investigators know that treatment for prostate cancer and erectile dysfunction can impact sexual health and quality of life. They want to learn how the treatment affects one's emotional and social well-being.

They have developed a new type of counseling. Cancer patients seek counseling for lots of reasons. It often helps them cope because they can express their feelings with a trained professional. They hope that this counseling will teach patients skills that they can use to comply with erectile treatment programs, improve their sexual health and quality of life. These skills may also improve physical and emotional well-being. As part of this study they will ask the patient to provide feedback on the proposed counseling.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Part A

Men who are 1 to 3 years post radical prostatectomy for early stage prostate cancer
Participated in penile injection program
Are able to speak, read, write and understand English well enough to complete study assessment and communicate with an English speaking therapist

Part B

Men who are up to 9 months post radical prostatectomy.
Had good erectile functioning pre-surgery (i.e., 24 or greater on the IIEF Erectile Function Domain (EFD) score), graded their erections as a 1 or 2 on the standard 5 point Urology Erectile Function scale) or have a score of 7 or greater on the 1-10 pre-surgery erectile function scale on the SMRP assessment)
Seen at MSKCC"s Sexual Medicine Rehabilitation Program (SMRP)
Advised by the clinical staff of the SMRP to start penile injections.

Exclusion Criteria:

Part A

Recurrence or progression of disease,
Specific injection phobia (self report)
A history of bipolar disorder or psychotic disorder (determined from self-report and/or chart review)
Current major depression (determined by self report and/or clinician observation and assessment) that would preclude from giving informed consent or being an active participant in a focus group

Part B

Specific injection phobia (self report)
A history of bipolar disorder or psychotic disorder (determined from self-report and/or chart review)
Current major depression (determined by self report and/or clinician observation and assessment) that would preclude from giving informed consent or being an active participant in a therapeutic session.

Study is for people with:

Prostate Cancer

Estimated Enrollment:

99

Study ID:

NCT01275404

Recruitment Status:

Completed

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

99

Study ID:

NCT01275404

Recruitment Status:

Completed

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider